Transperineal vapor ablation systems and methods

US2020397495A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2020397495-A1
Application numberUS-202016919499-A
CountryUS
Kind codeA1
Filing dateJul 2, 2020
Priority dateJan 6, 2017
Publication dateDec 24, 2020
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A vapor delivery needle is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply condensable vapor energy to tissue, such as a prostrate, to shrink, damage, or denature tissues of the prostate. Methods associated with use of the energy delivery probe are also covered.

First claim

Opening claim text (preview).

1 .- 15 . (canceled) 16 . A vapor delivery device comprising: a shaft; a first electrode disposed at a distal tip of the shaft, wherein the first electrode is configured to measure a first electrical impedance of a first tissue contacting the first electrode; a second electrode disposed on the shaft, proximally of the first electrode, wherein the second electrode is configured to measure a second electrical impedance of a second tissue contacting the second electrode; and an electrically insulative material disposed between the first electrode and the second electrode; and an electronic controller configured to use the first electrical impedence and the second electrical impedence in order to determine whether the first electrode and the second electrode are disposed within a prostate. 17 . The vapor delivery device of claim 16 , wherein the second electrode is a ring electrode. 18 . The vapor delivery device of claim 16 , wherein the first electrode is configured to measure a first phase shift of the first tissue. 19 . The vapor delivery device of claim 18 , wherein the second electrode is configured to measure a second phase shift of the second tissue. 20 . The vapor delivery device of claim 19 , wherein the controller is configured to use the first phase shift and the second phase shift in order to determine whether the first electrode and the second electrode are disposed within the prostate. 21 . The vapor delivery device of claim 16 , wherein the shaft includes at least one hole configured to delivery vapor to the prostate. 22 . The vapor delivery device of claim 16 , further comprising circuitry electrically connected to the first electrode and the second electrode, wherein the circuitry is configured to provide a variable frequency. 23 . The vapor delivery device of claim 16 , wherein vapor is deliverable by the shaft only when the first electrode and the second electrode are disposed within the prostate. 24 . A vapor delivery device comprising: a shaft terminating in a distal tip, wherein the distal tip includes a first electrode configured to measure a first electrical impedance of a first tissue contacting the first electrode, the shaft including: a second, ring electrode, proximal of the first electrode, configured to measure a second electrical impedance of a second tissue contacting the second electrode; and an electrically insulative material disposed between the first electrode and the second electrode. 25 . The vapor delivery device of claim 24 , further comprising: an electronic controller configured to use the first electrical impedence and the second electrical impedence in order to determine whether the first electrode and the second electrode are disposed within a prostate. 26 . The vapor delivery device of claim 24 , wherein the first electrode is configured to measure a first phase shift of the first tissue. 27 . The vapor delivery device of claim 26 , wherein the second electrode is configured to measure a second phase shift of the second tissue. 28 . The vapor delivery device of claim 24 , wherein the shaft includes at least one hole configured to delivery vapor to the prostate. 29 . The vapor delivery device of claim 24 , further comprising circuitry electrically connected to the first electrode and the second electrode, wherein the circuitry is configured to provide a variable frequency 30 . The vapor delivery device of claim 24 , wherein vapor is deliverable by the shaft only when the first electrode and the second electrode are disposed within the prostate. 31 . A vapor delivery device comprising: a shaft terminating in a distal tip, wherein the distal tip includes a first electrode configured to measure a first electrical impedance and a first phase shift of a first tissue contacting the first electrode, the shaft including: a second electrode, proximal of the first electrode, configured to measure a second electrical impedance and a second phase shift of a second tissue contacting the second electrode; and an electrically insulative material disposed between the first electrode and the second electrode. 32 . The vapor delivery device of claim 31 , further comprising: an electronic controller configured to use the first electrical impedence, the first phase shift, the second electrical impedence, and the second phase shift, in order to determine whether the first electrode and the second electrode are disposed within a prostate. 33 . The vapor delivery device of claim 31 , wherein the shaft includes at least one hole configured to delivery vapor to the prostate. 34 . The vapor delivery device of claim 31 , further comprising circuitry electrically connected to the first electrode and the second electrode, wherein the circuitry is configured to provide a variable frequency. 35 . The vapor delivery device of claim 31 , wherein vapor is deliverable by the shaft only when the first electrode and the second electrode are disposed within the prostate.

Assignees

Inventors

Classifications

  • A61B18/04Primary

    by heating (by applying electromagnetic radiation A61B18/18) · CPC title

  • Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically (A61M5/142 {, A61M5/46} take precedence; {hypodermic projectiles F42B12/54}) · CPC title

  • low, i.e. thermally insulating · CPC title

  • Alarms or notifications created in response to an abnormal condition · CPC title

  • open · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2020397495A1 cover?
A vapor delivery needle is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply condensable vapor energy to tissue, such as a prostrate, to shrink, damage, or denature tissues of the prostate. Methods associated with use of the energy delivery probe are also covered.
Who is the assignee on this patent?
Boston Scient Scimed Inc
What technology area does this patent fall under?
Primary CPC classification A61B18/04. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Dec 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).